Combination therapy with mitomycin C,5-fluorouracil, and cytosine arabinoside in P815 ascites and solid mouse neoplasms.
D000818:Animals; D003561:Cytarabine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use*; D051379:Mice; D008937:Mitomycins / Q000627:therapeutic use*; D009374:Neoplasms, Experimental / Q000188:drug therapy*
D008937:Mitomycins; D003561:Cytarabine; D005472:Fluorouracil